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Abstract: 
Background: Children with vesicoureteral reflux (VUR) are at risk of recurrent 
pyelonephritis, kidney scars, hypertension, and renal failure. Currently, VUR 
complications can be diagnosed by different imaging methods such as sonography, 
intravenous pyelography and dimercaptosuccinic acid (DMSA) scan, having 
certain limitations. Urinary level of ceruloplasmin (Cp) might be an effective non-
radiological method. The aim of this study was to compare the urinary level of Cp 
with DMSA scan in the diagnosis of VUR complications.  
Methods: The present cross-sectional study was conducted in Pediatric Research 
Center of Qom University of Medical Sciences and Health Services, Iran. Subjects 
consisted of 61 children with VUR, diagnosed by voiding cystoureterography 
(VCUG) and undergone either DMSA scan or urine Cp measurement. VUR stages 
and complications of the cases were evaluated using serum and urinary renal 
parameters. Data were analyzed using SPSS 22. 
Results: Among them, 80.3% were girls with a mean age of 7.2±3.8 years. Mean 
Cp urine level was statistically different between VUR sides in DMSA scan 
(unilateral: 269.56 vs. bilateral: 450.42 µg/dL) (P=0.034, r =0.273), but was not 
statistically different among various VUR degrees (P=0.102, r=0.211), different 
ages and genders (P>0.05).  
Conclusions: Urinary level of Cp was not statistically different among VUR 
degrees, but was higher in bilateral VUR cases, indicating Cp can be used as a safe, 
non-invasive, and cheap measurement tool for screening test. Further studies are 
required to confirm Cp as an effective method. 
Key Words: Children, Urinary tract infection, Ceruloplasmin, Sonography, 
Vesicoureteral reflux, DMSA 
 
 
 
 
 
 
Introduction: 
Vesicoureteral reflux (VUR) is defined as retrograde urine flow from the 
bladder into the ureter and kidney secondary to a dysfunctional vesicoureteral 
junction 
[1, 2]
. VUR is the most common congenital urinary tract abnormality in 
children that usually presents with urinary tract infection (UTI) 
[2]
. VUR is 
conventionally diagnosed and followed-up by VCUG and classified into five 
grades (I to V). Grade I is reflux into the ureter, grade II into the renal pelvis and 
calyces without any dilation of the calyces, grade III into the renal pelvis with mild 
dilation of the ureter, grade IV into the renal pelvis with greater dilation of the renal 
pelvis, and grade V into the renal pelvis with ureteral and pelvic dilation 
[3, 4]
. 
Vesicoureteral reflux is associated with severe complications, especially in children 
older than 1 year and with higher disease grades 
[4]
. The scars which lie more at the 
poles are composed preferentially of compound papillae (concave architecture) 
compared with the middle site of kidneys. The former are more  
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commonly the site of intrarenal reflux and are the prime 
regions of susceptibility to scarring 
[1, 2]
.  
When VUR associated with intrarenal reflux, it 
decreases the renal function and increases UTI 
incidence 
[4, 5]
. Vesicoureteral reflux may also resolve 
spontaneously 
[6]
, but complications may occur even 
after resolution of VUR, one of the most important 
complications is the renal scarring, also known as 
reflux nephropathy 
[6, 7]
. Sterile reflux is considered 
benign, while VUR exploits several conditions that 
predispose to scarring. Most importantly, reflux 
provides a mechanical hydrodynamic mechanism 
which facilitates the ascension of bacteria from the 
bladder to the kidneys 
[3, 6]
. 
Therefore, appropriate diagnosis of VUR is 
essential, not only for the initial diagnosis, but also for 
occurrence of complications, even in cases with 
resolved VUR. 
Various investigations have tried to determine the 
diagnostic accuracy of different imaging techniques. 
As suggested by previous research, ultrasonography 
has a low sensitivity and predictive value for diagnosis 
of VUR 
[8]
, and renal scars 
[8, 9]
. In addition, 
ultrasonography, alone or in combination with 
dimercaptosuccinic acid (DMSA) scan, cannot predict 
the complication of low grade VUR 
[10, 11]
, which has 
higher probability of spontaneous resolution of VUR 
and should be considered for occurrence of 
complications with greater precision 
[6]
.  Moreover, 
although DMSA scan is introduced as the most reliable 
method for diagnosis of renal scars 
[12]
, it has several 
limitations (it is invasive and expensive) [13]. Therefore, 
it is essential to find an appropriate diagnostic method 
for follow-up of patients with VUR. 
Ceruloplasmin (Cp) is an acute phase reactant. Cp 
is an acute-phase glycoprotein that may increase in 
blood in response to infection, inflammation, some 
cancers and trauma and acts through interleukin-6. it is 
expressed in several organs, such as spleen, lung, testis, 
retina, and brain astrocytes, as well as glomerular 
parietal epithelial cells and is secreted into urine 
[14]
.  
Thus, measurement of urinary levels of Cp is 
suggested for detection of nephropathy and micro-
albuminuria in diabetic patients 
[15]
. Increased 
concentration of Cp has been recently suggested as a 
marker of endothelial dysfunction and organ damage 
[16]
 and kidney protection against iron excess damage 
[17]
 In addition, Cp can be used as a marker of damaged 
renal cells and may be increased in VUR stages and 
complications 
[16]
. 
Due to the complications of VCUG as an invasive 
method, complexity and possible bias of DMSA scan, 
the hypothesis of efficacy of measurement of urinary 
Cp levels as a simple and inexpensive laboratory 
method for diagnosis of VUR complications seems 
valuable to be further studied in children with VUR. 
Therefore, the aim of the current study was to compare 
diagnostic accuracy of urinary Cp levels with DMSA 
scan for VUR complications. 
 
 
Materials and Methods 
Study design 
The present cross-sectional study was conducted in 
Pediatric Research Center and approved by the Ethics 
Committee of Qom University of Medical Sciences 
(code: IR.MUQ.REC.1393.121). Children referred to 
Nephrology Center of Hazrat-e- Masoumeh Hospital 
from 2015 to 2016 and diagnosed with VUR by VCUG 
were entered into the study. Any patient with acute 
urinary infection during the study period, congenital or 
genetic kidney diseases, and metabolic diseases was 
excluded from the study population. The study design 
and objectives were explained to the parents of the 
children and the written informed consent was obtained 
from them. All patients with proven VUR were 
evaluated using DMSA scan, and the urinary Cp level 
was measured for detecting kidney damage. We 
selected a group of children with VUR for the 
assessment of VUR complications 6 months after 
treatment of UTI. 
A blood sample (5 cc) was collected from all 
participants and taken from median cubital vein of 
child in sitting position. After sampling, all blood 
samples were kept in heparinized tubes and directly 
sent to reference laboratory. Means of serum and urine 
creatinine were measured for all participants. Mean 
urinary Cp level was measured in 24-hour urine by 
Abnova the CP (Human) ELISA Kit made in Taiwan. 
The samples were stored at -20℃. Urinary Cp 
concentration on average is 1.25-320 ng/mL. 
DMSA scan was performed by one radiologist via 
injection of 2 mCi 99mTc- DMSA. Three hours after 
injection, scanning was performed in multiple 
projections. All images were reviewed on the monitor's 
screen. DMSA is currently the accepted gold standard 
for diagnosing acute pyelonephritis and renal scarring 
but decreased uptake can be due to dysplasia, cyst and 
hydronephrosis 
[18]
. In this study, VUR is classified into 
three grades: mild (Grade 1, 2), moderate (Grade 3, 4) 
and sever (Grade 5). 
Statistical analysis 
Analysis included descriptive and inferential 
analysis; descriptive analysis consisted of mean ± SD 
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for quantitative variables and percentage of categorical 
variables was compared using t-test and chi-square test, 
respectively. The association of variables was tested by 
Pearson's correlation coefficient, with the help of 
Rock's curve. For the statistical analysis, SPSS 16 was 
used. P values of ≤0.05 were statistically considered 
significant. 
 
 
Results: 
A total of 80 children of this study, 61 patients 
completed the study protocol, among whom 49 
(80.3%) were girls and 12 (19.7%) were boys with a 
mean±SD age of 7.2±3.8 years. The results of 
creatinine were expressed in mg/dl. Erel's Cp 
measurement method was used. This method is 
automated, colorimetric and based on the enzymatic 
oxidation of ferrous ion to ferric ion. The results were 
declared in mg/dl, and the precision of this assay is 
within 3%. Mean±SD serum creatinine was 
254.723±173.61 mg/dl, and mean urinary Cp level was 
352.58±333.41 µg/dl in all participants. Mean ratio of 
urine Cp/cr was 1.45±1.14. Mean urinary Cp level was 
371.23 µg/dl in girls and 276.41 µg/dl in boys 
(P=0.382). 
The degrees of vesicoureteral reflux and scar 
severity diagnosed by DSMA are shown in Table 1. 
Mean urinary Cp level was statistically different 
between uni- and bi-lateral VUR in DMSA scan and 
was higher in bilateral cases (269.56 µg/dl in unilateral 
vs. 450.42 µg/dl in bilateral) (P=0.034, Pearson 
coefficient: r=0.273). However, the mean urinary Cp 
level was not statistically different among VUR 
degrees (P=0.102, Pearson coefficient: r=0.211), or 
among different ages (P=0.71, Pearson coefficient: 
r=0.233). Mean urinary Cp was associated with age, 
VUR degree, and kidney scar degree, as shown in 
figures 1, 2, 3. Pearson's coefficient of the association 
of urinary Cp and scar severity in the study population 
is illustrated in table 2. 
This manuscript in the present form just can 
represent the association between CP level and DMSA 
scan. The data do not support the CP level as a 
screening method. The authors only examined the CP 
level among patients with VUR. If the CP level was 
measured among healthy children (no VUR), the 
specificity of the test would be estimated. Otherwise, 
the test cannot be considered as screening test. 
 
 
Table 1. The degree of vesicoureteral reflux and scar severity diagnosed by DSMA scan in the study population 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Pearson's coefficient of the association of urinary ceruloplasmin and scar severity in the study 
population 
DSMA scan Pearson’s coefficient (r) P-value 
Uni/bilateral 0.273 0.034 
VUR Degree 0.211 0.102 
Renal Scar stage 0.233 0.71 
 
DSMA scan Frequency (%) 
VUR Degree 
Mild 29(47.5) 
Moderate 26(42.6) 
Severe 6(9.8) 
Uni/bilateral VUR 
Unilateral 33(54.1) 
Bilateral 28(45.9) 
Renal Scar stage 
Stage 1 23(37.7) 
Stage 2 21(34.4) 
Stage 3 14(23.0) 
Stage 4 3(4.9) 
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Figure 1. Mean urinary Cp in different ages in the study population 
 
 
Figure 2. Mean urinary Cp in different stages of VUR in the study population 
 
 
Figure 3. Mean urinary Cp in different stages of scar in the study population 
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Discussion: 
Children with VUR, diagnosed by voiding 
cystoureterography (VCUG) and undergone either 
DMSA scan or urine Cp measurement were selected in 
the present study. VUR stages and complications of the 
cases were evaluated using serum and urinary renal 
parameters. In the current study, we examined the 
hypothesis of renal over-excretion of Cp that has been 
proven by higher concentration of urinary Cp in 
children with VUR, statistically higher in bilateral 
cases. Among all participants, 80.3% were girls with 
the mean age of 7.2±3.8 years, and the mean level of 
urinary Cp was 352.58±333.41 µg/dl, which was 
higher than the normal range. Mean Cp urine level was 
statistically different between VUR sides (unilateral: 
269.56 vs. bilateral: 450.42 µg/dl) (P=0.034, r =0.273), 
but was not statistically different among various VUR 
degrees (P=0.102, r=0.211), different ages and genders 
(P>0.05). These results indicate that Cp is excreted 
more in renal damaged cells, but Cp cannot 
differentiate VUR stages. 
To the best of our knowledge, urinary Cp level was 
measured for the first time in children with VUR in this 
study. As Cp is expressed in glomerular parietal 
epithelial cells and secreted into urine 
[14]
, and 
increased Cp level is also described as a marker of 
endothelial dysfunction and organ damage 
[16]
 
previously, we hypothesized that Cp is able to be used 
as a marker of damaged renal cells and may be 
increased in VUR stages and complications. Previous 
studies have suggested urinary Cp increases due to 
nephropathy and other renal disorders, but have mainly 
focused on diabetic nephropathy 
[19]
. Narita et al. have 
also reported increased urinary levels of Cp in diabetic 
patients with micro-albuminuria 
[20]
. Cp is an anti-
oxidant with specific characteristics; for instance, 
copper is released from Cp under acidic conditions in 
diabetic patients and higher Cp is filtered through 
damaged glomerulus 
[21]
. The results of these studies 
indicated higher urinary concentrations of Cp in 
patients with damaged kidneys, which is in line with 
the results of the present study, indicating higher total 
mean level of urinary Cp than normal range in all 
participants with VUR. Although the above-mentioned 
studies focused on patients with diabetes type 2, the 
study population consisted of children with VUR. 
VUR predisposes to urinary tract infection (UTI) 
through facilitating the transport of pathogen bacteria 
to the upper urinary tract, also inflammatory reaction 
caused by UTI can result in reflux nephropathy (RN). 
RN is a result of abnormal renal development, leading 
to focal or extended renal dysplasia 
[(21]
. 
As Cp is expressed in several organs such as liver, 
spleen, lung, testis, retina, and brain 
[14]
, researchers 
have investigated the association of Cp levels with 
different diseases of these organs and have focused on 
the significance of detection and prediction of diseases 
with Cp, hypothesized to act through nitric oxide (NO) 
activity 
[22]
. Accordingly, serum levels of Cp are related 
to cardiovascular disorders and play an important iron-
mediated injury role 
[23]
.  
It is supposed to be able to assess vascular 
inflammation and hence predict acute coronary events 
[24]
 and metabolic syndrome in adolescents 
[25]
. Further 
research has revealed the association of Cp with liver 
diseases like hepatic steatosis 
[26].
 Also, Cp has been 
linked with brain diseases such as Alzeihmer's 
[27]
, 
Parkinson's disease 
[28]
 and psychiatric patients with 
suspicion of Wilson disease (WD) should be evaluated 
in a reference center 
[29]
. 
In one study, a renal-specific excellent novel urine 
biomarker panel for the recognition of active lupus 
nephritis (LN) was done. The levels were significantly 
higher in those patients with active LN than in non-LN 
patients [all corrected p values (pc) < 0.05] across both 
cohorts 
[30]
. 
Finally, a number of potential limitations might 
have affected the results of the present research. First, 
the considerable percentage of loss to follow-up cases 
resulted in the investigation of 61, instead of 80 
patients. Moreover, the present study assessed children 
with VUR, referred to one center and the results might 
not be representative of the whole population. Further 
multicentric studies with longer follow-up and greater 
sample size can better illustrate the significance of this 
hypothesis.  
According to the results of the present study, 
although urinary levels of Cp could not differentiate 
VUR degrees, its higher concentrations in total 
population of children with VUR as well as in bilateral 
than unilateral cases indicated the higher excretion of 
Cp from damaged renal cells, indicating the use of this 
simple, easy, and inexpensive laboratory method as an 
effective measurement tool in complications of VUR. 
This study can be considered as the initial step to the 
implementation of urinary measurement of Cp levels as 
a feasible and easy method, which can be confirmed by 
future research.  
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